Pancreatic Cancer Treatment Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc

Size: px

Start display at page:

Download "Pancreatic Cancer Treatment Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc"

Sara James
4 years ago
Views:

Pancreatic Cancer Treatment Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The rising prevalence f besity, alchl cnsumptin, and smking is expected t

Increasing tbacc cnsumptin, smking, besity, and grwing awareness pertaining t varius treatment ptins available are prpelling the market grwth at a glbal level.

Accrding t an article published in the Natinal Center fr Bitechnlgy Infrmatin in 2015, pancreatic cancer is ne f the mst dangerus malignancies and is the furth mst cmmn cause f cancer deaths in the U.

1 Pancreatic Cancer Treatment Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The rising prevalence f besity, alchl cnsumptin, and smking is expected t prpel the Pancreatic Cancer Treatment market grwth.. The glbal Pancreatic Cancer Treatment Market is expected t reach USD 4.2 billin in 2025, accrding t a new reprt by Grand View Research, Inc. Increasing tbacc cnsumptin, smking, besity, and grwing awareness pertaining t varius treatment ptins available are prpelling the market grwth at a glbal level. The peak incidence f pancreatic cancer is seen in the age grup f 65 t 75 years. Thus, grwing geriatric ppulatin is als expected t drive the grwth during the frecast perid. Accrding t an article published in the Natinal Center fr Bitechnlgy Infrmatin in 2015, pancreatic cancer is ne f the mst dangerus malignancies and is the furth mst cmmn cause f cancer deaths in the U.S. Furthermre, pancreatic cancer is expected t be the secnd cmmn cause f death in the U.S., by These factrs tgether wuld prpel the market grwth in the frecast perid. T request a sample cpy r view summary f this reprt, click the link belw: Further key findings frm the study suggest:

2 The study suggests that excrine cancer is by far the mst cmmn type f pancreatic cancer accunting fr mre than 95% f the verall pancreatic cancer types Amng the treatment types, targeted therapy ccupied the largest share since it is cnsidered as the mst effective treatment ptin, which blcks the grwth and spread f cancer cells withut damaging healthy cells Nrth America dminated the segment with the largest revenue share in 2015 due t high adptin rate f advanced treatment ptins and highly develped healthcare infrastructure Asia Pacific is anticipated t shw a significant grwth during the frecast perid, mainly due t increasing gvernment initiatives, grwing awareness regarding the treatment ptins fr pancreatic cancer, and the availability f highly sphisticated medical infrastructure fr effective treatment Sme f the majr cmpanies perating in this market are, but are nt limited t, Eli Lilly and Cmpany; Celgene Crpratin; F. Hffmann-La Rche AG; Amgen, Inc.; Nvartis AG; PharmaCyte Bitech, Inc.; Clvis Onclgy; Teva Pharmaceutical Industries Ltd.; Merck & C., Inc.; and Pfizer, Inc. Grand View Research has segmented the pancreatic cancer treatment market n the basis f affected regin, treatment, and regin: Pancreatic Cancer Treatment Affected Regin Outlk (Revenue, USD Millin, ) Excrine Endcrine Pancreatic Cancer Treatment Outlk (Revenue, USD Millin, ) Chemtherapy Targeted Therapy Others Pancreatic Cancer Treatment Reginal Outlk (Revenue, USD Millin, ) Nrth America

3 U.S. Canada Eurpe Germany UK Asia Pacific China Japan Latin America Brazil Mexic MEA Suth Africa

4 Table f Cntent f Pancreatic Cancer Treatment Market Chapter 1 Research Methdlgy 1.1 Infrmatin Prcurement 1.2 Data Analysis 1.3 Appraches fr Market Estimatin Apprach 1: Demand analysis & bttm-up apprach Apprach 2: Tp-dwn market estimatin Apprach 3: Cmmdity flw and bttm-up market estimatin Apprach 4: KL perspective-based market sizing Chapter 2 Executive Summary 2.1 Market Snapsht Chapter 3 Pancreatic Cancer Treatment Market Variables, Trends & Scpe 3.1 Market Segmentatin 3.2 Market Size and Grwth Prspects Market driver analysis Market restraint analysis 3.3 Key Opprtunities Priritized 3.4 Industry Analysis Prter s 3.5 PESTEL Analysis Chapter 4 Pancreatic Cancer Treatment Market: Affected Regin Estimates & Trend Analysis 4.1 Pancreatic Cancer Treatment Market: Affected Regin Mvement Analysis 4.2 Excrine Market estimates and frecasts, (USD Millin) 4.3 Endcrine Market estimates and frecasts, (USD Millin) Chapter 5 Pancreatic Cancer Treatment Market: Treatment Estimates & Trend Analysis 5.1 Pancreatic Cancer Treatment Market: Treatment Mvement Analysis 5.2 Chemtherapy Market estimates and frecasts, (USD Millin) 5.3 Targeted Therapy

5 5.3.1 Market estimates and frecasts, (USD Millin) 5.4 Others Market estimates and frecasts, (USD Millin) Chapter 6 Pancreatic Cancer Treatment Market: Reginal Estimates & Trend Analysis, by Affected regin & Applicatin 6.1 Pancreatic Cancer Treatment Market Share by Regin, 2015 & Nrth America U.S Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin, Canada Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin, Eurpe U.K Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin, Germany Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin, Asia Pacific China Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin, Japan Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin, Latin America Brazil Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin,

6 6.5.2 Mexic Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin, MEA Suth Africa Market estimates and frecasts, by affected regin, Market estimates and frecasts, by applicatin, Chapter 7 Cmpetitive Landscape 7.1 Strategy framewrk 7.2 Cmpany Prfiles Eli Lily and Cmpany Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives Celgene Crpratin Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives Hffmann-La Rche AG Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives Amgen, Inc Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives Nvartis AG

7 Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives PharmaCyte Bitech, Inc Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives Clvis Onclgy Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives Teva Pharmaceutical Industries Ltd Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives Merck & C., Inc Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives Pfizer, Inc Cmpany verview Financial perfrmance Prduct benchmarking Strategic initiatives

8 Abut Us: Grand View Research, Inc. is a U.S. based market research and cnsulting cmpany, registered in the State f Califrnia and headquartered in San Francisc. The cmpany prvides syndicated research reprts, custmized research reprts, and cnsulting services. T help clients make infrmed business decisins, the cmpany ffers market intelligence studies ensuring relevant and fact-based research acrss a range f industries including technlgy, chemicals, materials, healthcare and energy. Cntact: Sherry James Crprate Sales Specialist, USA Grand View Research, Inc Phne: Tll Free: sales@grandviewresearch.cm Fr Mre Infrmatin: Blg:

Intracranial Pressure (ICP) Monitoring Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc

Intracranial Pressure (ICP) Monitoring Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc Intracranial Pressure (ICP) Mnitring Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal intracranial pressure mnitring devices market is expected t